House Has Slim Boost For FDA FY2023 Spending, But Wants Slimmer Budget Document From Agency
Executive Summary
Appropriations Committee publishes FY2023 spending bill and report FDA day before it votes on the legislation. It recommends increasing FDA’s budget by less than $400m from its current appropriation to $6.48bn.
You may also be interested in...
Senate Proposes Smaller Boost Than House For FDA FY2023 Appropriation
A proposed budget from the US Senate appropriations committee would fund the FDA's device activities at $663m for fiscal 2023, marking a modest increase from 2022 but a drop from House and administration requests.
Senate Proposes Smaller Boost Than House For FDA FY2023 Appropriation
Senate Appropriations Committee proposes $1.185bn to CFSAN and $2.19bn to CDER, both levels short of House appropriators passed in June. FDA requested $30.36m in user fees from monograph drugs but no amount was specified in Senate draft bill.
Honey Sachets Are Latest Sweet Spot For Selling Products With Undisclosed ED Drugs In US
FDA's warnings to four companies selling honey sachets containing undisclosed ED ingredients are latest examples of businesses marketing noncompliant products because the agency doesn't have sufficient funding to regulate the market, says University of Connecticut pharmacy professor Michael White.